A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm

Kowalski A : Pathway to artificial pancreas systems revisited: moving downstream. Diabetes Care, 2015; 38:1036–1043.

Kowalski AJ : Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. Diabetes Technol Ther, 2009; 11(Suppl 1):S113–S119.

Tanenbaum ML , Hanes SJ , Miller KM , et al.: Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care, 2017; 40:181–187.

Forlenza GP , Buckingham B , Maahs DM : Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J Pediatr, 2016; 169:13–20.

Kropff J , DeVries JH : Continuous glucose monitoring, future products, and update on worldwide artificial pancreas projects. Diabetes Technol Ther, 2016; 18(Suppl 2):S253–S263.

Weiss R , Garg SK , Bode BW , et al.: Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE in-home study. Diabetes Technol Ther, 2015; 17:542–547.

Garg SK , Brazg RL , Bailey TS , et al.: Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther, 2014; 16:125–130.

Choudhary P , Olsen BS , Conget I , Welsh JB , et al.: Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Ther, 2016; 18:288–291.

Forlenza GP , Li Z , Buckingham BA , et al.: Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care, 2018; 41:2155–2161.

Wood MA , Shulman DI , Forlenza GP , et al.: In-clinic evaluation of the MiniMed 670G System “Suspend Before Low” feature in children with type 1 diabetes. Diabetes Technol Ther, 2018; 20:731–737.

Doyle FJ , Huyett LM , Lee JB , et al.: Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care, 2014; 37:1191–1197.

Weisman A , Bai JW , Cardinez M , et al.: Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol, 2017; 5:501–512.

Bergenstal RM , Garg S , Weinzimer SA , et al.: Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA, 2016; 316:1407–1408.

Messer LH , Forlenza GP , Sherr JL , et al.: Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G System. Diabetes Care, 2018; 41:789–796.

Garg SK , Weinzimer SA , Tamborlane WV , et al.: Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19:155–163.

Bekiari E , Kitsios K , Thabit H , et al.: Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ, 2018; 361:k1310.

Quemerais MA , Doron M , Dutrech F , et al.: Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study. J Diabetes Sci Technol, 2014; 8:1177–1184.

Buckingham BA , Forlenza GP , Pinsker JE , et al.: Safety and feasibility of the OmniPod hybrid closed-loop system in adult, adolescent, and pediatric patients with type 1 diabetes using a personalized model predictive control algorithm. Diabetes Technol Ther, 2018; 20:257–262.

El-Khatib FH , Balliro C , Hillard MA , et al.: Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet, 2017; 389:369–380.

Tauschmann M , Allen JM , Wilinska ME , et al.: Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care, 2016; 39:1168–1174.

Brown S , Raghinaru D , Emory E , Kovatchev B : First look at Control-IQ: a new-generation automated insulin delivery system. Diabetes Care, 2018; 41:2634–2636.

Buckingham BA , Christiansen MP , Forlenza GP , et al.: Performance of the Omnipod personalized model predictive control algorithm with meal bolus challenges in adults with type 1 diabetes. Diabetes Technol Ther, 2018; 20:585–595.

Lewis D : History and perspective on DIY closed looping. J Diabetes Sci Technol, 2018. [Epub ahead of print]; DOI: 1932296818808307.

Samadi S , Rashid M , Turksoy K , et al.: Automatic detection and estimation of unannounced meals for multivariable artificial pancreas system. Diabetes Technol Ther, 2018; 20:235–246.

Ramkissoon CM , Herrero P , Bondia J , Vehi J : Unannounced meals in the artificial pancreas: detection using continuous glucose monitoring. Sensors (Basel), 2018; 18:E884.

Forlenza GP , Cameron FM , Ly TT , et al.: Fully Closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting. Diabetes Technol Ther, 2018; 20:335–343.

Cameron FM , Ly TT , Buckingham BA , et al.: Closed-loop control without meal announcement in type 1 diabetes. Diabetes Technol Ther, 2017; 19:527–532.

Chernavvsky DR , DeBoer MD , Keith-Hynes P , et al.: Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes, 2016; 17:28–35.

Elleri D , Maltoni G , Allen JM , et al.: Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial. Diabetes Obes Metab, 2014; 16:1174–1178.

Gingras V , Rabasa-Lhoret R , Messier V , et al.: Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: a randomized crossover trial. Diabetes Metab, 2016; 42:47–54.

Blauw H , van Bon AC , Koops R , et al.: Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home. Diabetes Obes Metab, 2016; 18:671–677.

van Bon AC , Brouwer TB , von Basum G , et al.: Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther, 2011; 13:731–736.

Messer LH : Why expectations will determine the future of artificial pancreas. Diabetes Technol Ther, 2018; 20(Suppl 2):S265–s268.

Messer LH , Forlenza GP , Wadwa RP , et al.: The dawn of automated insulin delivery: a new clinical framework to conceptualize insulin administration. Pediatr Diabetes, 2018; 19:14–17.

Berget C , Thomas SE , Messer LH , et al.: A clinical training program for hybrid closed loop therapy in a pediatric diabetes clinic. J Diabetes Sci Technol, 2019. [Epub ahead of print]. DOI: 10.1177/1932296819835183

Kovatchev B , Patek S , Dassau E , et al.: Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol, 2009; 3:1058–1065.

Wadwa RP , Laffel LM , Shah VN , Garg SK : Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes. Diabetes Technol Ther, 2018; 20:395–402.

Shah VN , Laffel LM , Wadwa RP , Garg SK : Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther, 2018; 20:428–433.

Slover RH , Tryggestad JB , DiMeglio LA , et al.: Accuracy of a fourth-generation continuous glucose monitoring system in children and adolescents with type 1 diabetes. Diabetes Technol Ther, 2018; 20:576–584.

Olafsdottir AF , Attvall S , Sandgren U , et al.: A clinical trial of the accuracy and treatment experience of the flash glucose monitor FreeStyle libre in adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19:164–172.

Forlenza GP , Messer LH , Berget C , et al.: Biopsychosocial factors associated with satisfaction and sustained use of artificial pancreas technology and its components: a call to the technology field. Curr Diab Rep, 2018; 18:114.

Messer LH , Berget C , Beatson C , et al.: Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther, 2018; 20(Suppl 2):S254–s264.